Back to Woodline Partners LP Woodline Partners LP

URGNURGN
Showing 8 of 9 quarters

Position history for Woodline Partners LPWoodline Partners LP's holdings in UROGEN PHARMA LTD

Yes. Woodline Partners holds 500,726 shares of URGN (Urogen Pharma), worth $18.4M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Woodline Partners has held URGN since Q2 2024, across 9 quarterly 13F filings. URGN is 0.1% of Woodline Partners' reported 13F portfolio.

Current Value

$18.4M

Current Shares

500,726

Total Value Change

+$14.5M

Total Shares Change

+195,084

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
500,726
0.0%
$18.4M0.1%$36.80
0
2026-Q1
Unchanged
500,726
0.0%
$9M0.0%$17.98
0
2025-Q4
Increased
500,726
+63.4%
$11.7M0.0%$23.42
41
2025-Q3
Decreased
306,371
-0.1%
$6.1M0.0%$19.95
0
2025-Q2
Increased
306,724
+0.1%
$4.2M0.0%$13.70
27
2025-Q1
Increased
306,371
+0.2%
$3.4M0.0%$11.06
26
2024-Q4
Unchanged
305,642
0.0%
$3.3M0.0%$10.65
0
2024-Q3
Increased
305,642
+0.6%
$3.9M0.0%$12.70
27

Other major holders of URGN: RTW INVESTMENTS, LP, BlackRock, Inc., MENORA MIVTACHIM HOLDINGS LTD.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used